Open access
Defining Age to Screen and Real‐World Effectiveness for Early‐Onset Colorectal Cancer
Medicine
Abstract
Implementation of a RAP‐based risk‐adapted screening strategy enables personalized screening initiation, with benefits comparable to those observed in the current 50–54‐year age group.